Document is current
Any future updates will be listed below
-
Authors
Forsberg, Matthew H.
Kink, John A.
Thickens, Anna S.
Lewis, Bryson M.
Childs, Charlie J.
Hematti, Peiman
Capitini, Christian M. https://orcid.org/0000-0002-2276-6731
-
Funding
Funding for this research was provided by:
National Cancer Institute (P30 CA014520, P30 CA014520, R01 CA215461)
St. Baldrick's Foundation (SU2C-AACR-DT-27-17, SU2C-AACR-DT-27-17)
National Center for Advancing Translational Sciences (UL1 TR000427, UL1 TR000427)
- License Information
-
More Information
Article History
Received: 17 February 2021
Accepted: 4 July 2021
First Online: 18 August 2021
Declarations
:
: All human cells were obtained by informed consent or waiver using IRB-approved protocols at the University of Wisconsin-Madison (2017-1070, 2016-0298). All animal studies were approved by the Animal Care and Use Committee at the University of Wisconsin-Madison (M005915).
: Not applicable
: P.H. and C.M.C. are inventors on a patent related to this publication (US Patent 10,166,254 B2). C.M.C. reports honorarium from Nektar Therapeutics and Novartis, who had no input in the study design, analysis, manuscript preparation, or decision to submit for publication. No other relevant conflicts of interest are reported.
